Over 1 Million Adults Rationed Insulin in 2021
Drug Topics
OCTOBER 18, 2022
Study examines patient action that ‘is frequently harmful, and sometimes deadly.’.
2021 Related Topics 
Flu Shot Reduced Outpatient Care Needed in 2021-2022 Flu Season
Drug Topics
JANUARY 4, 2023
Research on last season’s influenza vaccine efficacy bodes well for patients who have gotten their flu shot this season.
Vaccines 
468
468 Vaccines 468
468 Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Clears First Commercially Available Blood Test to Evaluate for TBI, Concussion
Drug Topics
MARCH 7, 2023
The test is intended to complement the company’s TBI plasma test, which received FDA clearance in 2021.
FDA 503
503 FDA 503
503 
For the First Time Medicaid Net Drug Spending Hits Double-Digits
Drug Topics
JANUARY 26, 2023
Spending on specialty drugs fueled a 11% increase in Medicaid drug spending from 2020 to 2021, says Magellan's seventh annual Medicaid Pharmacy Trend Report.
503 
Second Interchangeable Biosimilar for Insulin Glargine Approved by FDA
Drug Topics
NOVEMBER 17, 2022
Insulin glargine-aglr received initial FDA approval in December 2021.
FDA 464
464 FDA 464
464 
FDA Approves Tezepelumab for Self-Administration With New Pre-Filled Pen
Drug Topics
FEBRUARY 3, 2023
After being FDA approved in 2021, tezepelumab (Tezspire) has been approved again for self-administration.
FDA 464
464 FDA 464
464 
COVID-19 Currently A Leading Cause of Death Among Children and Young People
Drug Topics
FEBRUARY 6, 2023
A 2021 morbidity study found that COVID-19 was among the leading causes of death in children and young people.
469 
Health Care Spending Has Shot Back Up to Pre-Pandemic Levels
Drug Topics
APRIL 27, 2023
The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.
Insurance 452
452 Insurance 452
452 
STAT+: Bubble bursts: 2021 health tech IPOs and SPACs lose value, burn cash
STAT
SEPTEMBER 27, 2023
Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt.
128 
Brexit a key factor in worst UK medicine shortages in four years, report says
The Guardian - Pharmaceutical Industry
MARCH 22, 2025
Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021. Continue reading.
112 
New data: The 340B program is driving up costs for patients and our health care system
PhRMA
SEPTEMBER 16, 2022
billion in sales at the discounted 340B price in 2021. Guess what? The 340B program grew, yet again, hitting a whopping $43.9 But there has not been evidence of corresponding growth in care provided to vulnerable patients at 340B covered entities.
340 
Minority Communities, Independent Storefronts Hit Hardest by Pharmacy Closures
Drug Topics
DECEMBER 6, 2024
Researchers observed data from 2010 to 2021 to better understand recent trends in US pharmacy closures and the specific pharmacy types that have been impacted.
247 
340B program continues to drive shift in care to more expensive hospital settings
PhRMA
DECEMBER 15, 2022
In this case, the Berkeley Research Group (BRG) found that nearly 36% of all Medicare Part B therapy sales occurred at 340B hospitals in 2021 , up nearly 17 percentage points since 2012, meaning care is moving from physician offices and non-340B hospitals to 340B hospitals.
Hospitals 328
328 Hospitals 328
328 
FDA Approves Amivantamab-vmjw for Locally Advanced, Metastatic NSCLC With EGFR Exon 20 Insertion Mutation
Drug Topics
MARCH 1, 2024
The FDA granted accelerated approval to amivantamab-vmjw in May 2021.
FDA 247
247 FDA 247
247 
FDA: Nerivio Cleared for Migraine Prevention
Drug Topics
MARCH 2, 2023
Nerivio received clearance in January 2021 for use in acute migraine.
FDA 247
247 FDA 247
247 
RxPreferred to Offer Yusimry Through Mark Cuban's Online Pharmacy
Drug Topics
JULY 6, 2023
The Humira biosimilar is a tumor necrosis factor (TNF) blocker and was approved by the FDA in 2021.
FDA 247
247 FDA 247
247 
Pediatric Medical Spending on Mental Health Increased by 31% in 4-Year Period
Drug Topics
MARCH 12, 2024
In 2021, medical spending on pediatric mental health conditions accounted for 46.6% of all pediatric medical spending that year.
247 
FDA’s 2022 drug approvals fall short of recent norms
PharmaVoice
JANUARY 19, 2023
agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval.
246 
Medicare Part D Spending Reaches $48 Billion on Top 10 Drugs
Drug Topics
JULY 14, 2023
A Kaiser Family Foundation analysis found the 10 drugs accounted for more than half of the increase in gross Part D spending from 2018 to 2021.
247 
More Adults with Diabetes are Using Cannabis Despite Potential Risks
Drug Topics
JULY 23, 2024
From 2021 to 2022, the prevalence of adults with diabetes who used cannabis increased by 33.7%.
216 
STAT+: 23andMe files for bankruptcy as CEO Anne Wojcicki resigns
STAT
MARCH 24, 2025
It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap. The company will now try to sell itself through a court-supervised sale. In a statement released on Linkedin, Wojcicki made clear she plans to continue attempting to purchase 23andMe.
120 
Nonprofit hospitals received $37.4B in federal, local tax benefits in 2021, study finds
Fierce Healthcare
SEPTEMBER 25, 2024
The nonprofit hospital sector’s tax exemptions provide billions in estimated benefits, but about half of those exemptions are enjoyed by just a couple hundred hospitals, according to a newly publis | The analysis, meant to serve as a guide for policymakers, noted that the tax breaks are "highly concentrated" and vary "substantially" (..)
Hospitals 124
124 Hospitals 124
124 
STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database
STAT
JANUARY 13, 2025
DNA sequencer manufacturer Illumina has also invested $20 million in the project, which builds on a 2021 investment and partnership from Microsoft, which will provide the cloud infrastructure for the project. Pharmaceutical company Regeneron has invested $119.5 Continue to STAT+ to read the full story…
Medical Records 125
125 
New York Pharmacy Technician Requirements
Pharmacy Tech Scholar
SEPTEMBER 9, 2020
New York Pharmacy Technician Requirements *Completing the PharmacyTechScholar.com Online Course and Passing the PTCE meets the proposed 2021 credentialing/training requirements in New York New York… The post New York Pharmacy Technician Requirements appeared first on PharmacyTechScholar.com.
PTCE 221
221 PTCE 221
221 
Cardiovascular Death, Heart Failure Treatment Shows Positive Results in Phase 3 Study
Drug Topics
AUGUST 5, 2024
Finerenone (Kerendia) was previously approved in 2021 to reduce the risk of cardiovascular death, non-fatal myocardial infarction, hospitalization for heart failure, sustained eGFR decline, and end-stage kidney disease in adult patients with chronic kidney disease associated with type 2 diabetes.
Hospitals 190
190 Hospitals 190
190 
Study: Myocarditis Risk Is Significantly Higher After COVID-19 Infection Vs After Vaccine
Pharmacy Times
AUGUST 24, 2022
Analysis includes nearly 43 million individuals aged 13 year and older who received at least 1 dose in England between December 1, 2020, and December 15, 2021.
Vaccines 179
179 Vaccines 179
179 
Routine vaccinations drop among U.S. kindergartners for the third year in a row
STAT
JANUARY 12, 2023
kindergartners who’ve received standard childhood vaccines took a small but notable dip into the 2021-2022 school year, health officials said Thursday, amid disruptions related to Covid-19 and fears that anti-vaccine sentiment stirred up by the pandemic could be spreading to other shots. The percentage of U.S. Read the rest…
Vaccines 145
145 Vaccines 145
145 
Denied care: Trans men often struggle for inclusive gynecologic healthcare
Fierce Healthcare
FEBRUARY 26, 2024
When Joseph Schneier, a transgender man then in his early 40s, started experiencing unusual spotting and elevated progesterone levels in 2021, his partner urged him to get checked out. They could not have known it would take a year for Schneier to find a willing gynecologist who did not turn him away.
145 
STAT+: With $40 million, former DeepMind employees launch startup ‘laser-focused’ on AI protein design
STAT
FEBRUARY 12, 2025
In 2021, the company spun out Isomorphic Labs, an AI drug discovery company. The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2 , the protein structure prediction AI platform that “solved” a decades-old biology problem.
83 
New CDC Data Show Decrease in Vaccine Coverage Among Kindergarteners For 2023-2024 School Year
Pharmacy Times
OCTOBER 4, 2024
Significant polarization surrounding COVID-19 vaccinations in late 2020 and early 2021 looked to have had an impact in increasing vaccine hesitancy.
Vaccines 132
132 Vaccines 132
132 
Fierce Healthcare - Untitled Article
Fierce Healthcare
MARCH 12, 2025
A recent analysis, which looked at ophthalmology practice acquisitions between 2014 and 2021, outlines movement among the clinical workforce and changes in its characteristics that stem from private equity's increasing role in care.
120 
A Win for Indiana Patients: “Share the Savings” Legislation Now Law
PhRMA
MAY 8, 2023
Negotiations between pharmaceutical companies, health insurers, PBMs and others result in significant rebates and discounts that totaled $236 billion in 2021. However, those savings aren’t always shared with patients, which means there are patients who end up paying more for their medicine than their insurer and PBM.
From the ‘go-go days’ to a bubble crunch — the biotech sector faces its next challenge
PharmaVoice
SEPTEMBER 12, 2022
The highs of the sector in early 2021 gave way to a bear market that persisted into the second half of this year — but there's hope the bubble hasn't popped for good.
147 
Study Highlights Impact of Preventive Strategies for RSV Hospitalizations in Pediatric Patients
Pharmacy Times
OCTOBER 5, 2023
Study shows a a significant burden of hospitalizations associated with respiratory syncytial virus during the 2021-2022 season compared with the prepandemic period.
Hospitals 139
139 Hospitals 139
139 
KFF: A look at prior authorization trends in Medicare Advantage
Fierce Healthcare
AUGUST 12, 2024
Prior authorization denials in Medicare Advantage jumped between 2021 and 2022, according to a new analysis from KFF.
121 
FDA Reports Serious Liver Injury in Patients Without Cirrhosis Using Obeticholic Acid to Treat PBC
Pharmacy Times
DECEMBER 12, 2024
This update follows May 2021 guidelines which recommended patients with primary biliary cholangitis (PBC) with advanced cirrhosis discontinue obeticholic acid.
FDA 120
120 FDA 120
120 
M&A or affiliation improved rural hospitals' margins, reduced risk of closure: report
Fierce Healthcare
DECEMBER 2, 2024
The analysis, conducted by healthcare consulting firm Dobson DaVanzo, found that among 110 rural hospitals that closed between 2011 and 2021, more than half were standalone hospitals without support from larger systems.
Hospitals 130
130 Hospitals 130
130 
More health systems are billing for electronic patient-provider messages, study shows
Fierce Healthcare
JANUARY 11, 2024
After an early 2020 spike, monthly claims for e-visits rose from 64,000 in June 2021 to 107,000 by Sept. The total number of health systems with at least 50 logged claims also rose about 40% from Q3 2021 to Q3 2022.
118 
Pfizer, bracing for Hurricane Milton, pledges aid to emergency services and health support
Fierce Pharma
OCTOBER 8, 2024
Pfizer—which opened a global hub in Tampa, Florida, in 2021—is setting out to bolster emergency services, pool donations and ease medical supply needs as Hurricane Milton touches down this week. Editor's Note: Is your company bracing for Milton or working to provide aid in anticipation of the storm?
124 
Emergency medicine is grappling with a surprising problem: The prospect of too many physicians
STAT
OCTOBER 27, 2023
The American College of Emergency Physicians predicted in a 2021 study that there would be a surplus of nearly 8,000 emergency physicians by 2030. While much of the health care workforce is battling staff shortages, the emergency medicine field is trying to figure out how to manage a potential oversupply of physicians. Read the rest…
Hospitals 136
136 Hospitals 136
136 
Once a high-flying 'unicorn,' Olive AI sells two key businesses, winds down operations
Fierce Healthcare
OCTOBER 31, 2023
Healthcare startup Olive saw a meteoric rise in 2020 and 2021, spurred by the digital health funding boom and the need for automation during the COVID-19 pandemic. | It marks the end of the line for healthcare automation startup Olive AI.
136 
Opinion: Better safety studies could restore America’s confidence in vaccines
STAT
AUGUST 14, 2024
In February 2021, I received my second Covid-19 shot — the newly developed vaccine that would eventually save millions of lives worldwide — with great anticipation. It was as if an audible dog whistle began blaring right next to me.
Vaccines 145
145 Vaccines 145
145 
Decline in heart failure deaths has been undone, led by people under 45
STAT
APRIL 24, 2024
death certificate data from 1999 through 2021, revealing a steady drop in deaths until 2012, when rates plateaued, then began to rise steadily, and accelerated upward once the Covid-19 pandemic arrived. The concerning conclusion comes as newer medications are raising hopes for better outcomes in the years to come.
143 
Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics
STAT
OCTOBER 25, 2023
Since 2021, his lab here at the University of Pennsylvania has built algorithms to trawl genetic databases for protein fragments, called peptides, with microbe-squashing properties. PHILADELPHIA — Cesar de la Fuente believes the next breakthrough antibiotic might come from animals that have been dead for thousands of years.
145 
Let's personalize your content